Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Platinum Press Inc. (PPI) has commenced runs utilizing a digital printing system whose inks are free of volatile organic ...

Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.

AbbVie and ADARx Pharmaceuticals have signed a collaboration and license option agreement to develop small interfering RNA ...